Benchmark's 15min chart shows Bollinger Bands expanding downward, bearish Marubozu.

The 15-minute chart for Benchmark has recently exhibited a downward expansion of Bollinger Bands, accompanied by a bearish Marubozu candlestick pattern on August 14, 2025, at 12:15. This indicates that the market is currently being driven by selling pressure, with sellers exerting control over the market. Furthermore, the bearish momentum is likely to persist in the near future.

The 15-minute chart for Benchmark (BMRK) has recently exhibited a downward expansion of Bollinger Bands, accompanied by a bearish Marubozu candlestick pattern on August 14, 2025, at 12:15. This indicates that the market is currently being driven by selling pressure, with sellers exerting control over the market. Furthermore, the bearish momentum is likely to persist in the near future.

The Bollinger Bands, which measure volatility, have narrowed significantly, suggesting a period of consolidation and a decrease in the magnitude of stock price fluctuations. This pattern is more commonly associated with a continuation of the current trend rather than a potential breakout in either direction [1]. The Marubozu pattern, characterized by a long white candle with no shadows, further reinforces the bearish signal, indicating that sellers are in control. This pattern has been observed in other stocks such as Applied Industrial Technologies and Criteo, where it has been accompanied by other bearish indicators such as the KDJ Death Cross and the MACD Death Cross [2, 3].

Analysts from Benchmark Co. have maintained a Hold rating on Benchmark, with a focus on the Communication Services sector. According to TipRanks, Mark Zgutowicz, who covers Benchmark, has an average return of 14.5% and a 51.84% success rate on recommended stocks [4]. The current analyst consensus rating for Benchmark is Moderate Buy, with an average price target of $54.75 [4].

Recent corporate insider activity has shown a negative sentiment towards Benchmark. Over the past quarter, there has been an increase in insiders selling their shares, with a notable sale by Levien Meredith Kopit, a Director at Benchmark, who sold 4,225 shares for $200,476.25 in June 2025 [4].

In contrast, European companies listed on US markets have shown strong performance, with sectors like pharmaceuticals and hospitality outperforming tech and biotech firms. The S&P Europe Select ADR Index climbed 1.2% to 1,475.61, with Novo Nordisk surging 6.2% and InterContinental Hotels Group rising 7% [5].

Investors are increasingly favoring established companies with reliable pricing power and predictable cash flow, driven by persistent inflation and market volatility. This trend is evident in the performance of European companies listed in the US, which are enjoying a bigger share of the spotlight [5].

References:
[1] https://www.ainvest.com/news/bollinger-bands-narrowing-bearish-marubozu-triggered-calibercos-15min-chart-2508/
[2] https://www.ainvest.com/news/applied-industrial-technologies-triggers-bearish-signals-15-minute-kdj-chart-2508/
[3] https://www.ainvest.com/news/criteo-15-minute-chart-signals-bearish-trend-kdj-death-cross-bearish-marubozu-2508/
[4] https://www.theglobeandmail.com/investing/markets/stocks/BMRK/pressreleases/33882977/benchmark-co-keeps-their-hold-rating-on-maplebear-cart/
[5] https://finimize.com/content/european-pharma-and-hospitality-outperform-on-us-markets